Objective: The targeted vascular module in the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) consists of self-selected hospitals that choose to collect extra clinical details for better risk adjustment and improved procedure-specific outcomes. The purpose of this study was to compare patient selection and outcomes between targeted and nontargeted hospitals in the NSQIP regarding the operative management of abdominal aortic aneurysm (AAA).
There is a growing focus on tracking and improving outcome measures after surgery. [1] [2] [3] The Centers for Medicare and Medicaid Services have issued quality benchmarks that will be used to identify and reward hospitals who consistently meet these process measures. 4, 5 In addition, multiple professional societies have created their own data registries to track and improve outcomes through in-depth analysis of clinically relevant data. 1, 2 The American College of Surgeons National Surgical Quality Improvement Program (NSQIP) is a national clinical data set with a robust network of participating hospitals that share the goal of improving patient care through collective data sharing. In 2011, the NSQIP expanded its registry by creating targeted modules, which include additional clinical variables, to better answer controversies in selected clinical subspecialties with improved risk adjustment and focused analyses on more procedure-specific end points. Within the targeted vascular module, examples of novel variables include proximal aneurysm extent, symptom status (including ruptured aneurysm with or without hypotension), operative approach, and aneurysm diameter. As with the original (nontargeted) NSQIP, participating hospitals in these groups are self-selected. Participation in the targeted module adds additional cost to the hospital and requires a minimum of 1680 cases per year. Clinical reviewers sample eligible operations in the same way, but there is a possibility that targeted hospitals have more of their vascular surgery cases represented in the sample reported.
To date, the data on effectiveness of registries at improving care are conflicting. [6] [7] [8] [9] Furthermore, the generalizability of the analyses performed on selfselected "opt-in" clinical registries is often unknown. The additional variables in the targeted vascular module of the NSQIP are expected to provide better risk adjustment and a new wave of research on best practice and prediction tools, but the concern of generalizability remains. Targeted hospitals are thought to be higher volume referral centers that are more resource rich and with potentially better systems and process measures in place, leading some to believe that models based on targeted hospital data may not be generalizable. In addition, these hospitals are also thought to treat sicker patients with more difficult anatomy, potentially leading to worse outcomes, again calling into question how reliable results from this select group of hospitals may be. It is also possible that hospitals choosing to participate in the targeted module have quality of care gaps that they are attempting to correct with participation in this module. This study aimed to evaluate whether hospitals that choose to participate in the vascular targeted module operate on similar patients and whether they have similar mortality and morbidity compared with nontargeted hospitals.
METHODS
Data set. Using the NSQIP and targeted vascular NSQIP modules from 2011 to 2013, we identified all patients undergoing endovascular aneurysm repair (EVAR) or open abdominal aortic aneurysm (AAA) repair. The NSQIP, as of January 2015, had >390 nontargeted and >65 targeted hospitals contributing clinical data on patients after vascular surgery. Both targeted and nontargeted hospital modules contain all of the original NSQIP variables, which are referred to as nontargeted variables in this paper, compared with the additional targeted variables present only for those hospitals participating in the targeted vascular modules. Trained clinical reviewers identify potential procedures by reviewing operative case logs, then collect data and categorize procedures using Current Procedural Terminology (CPT) codes at both the targeted and nontargeted NSQIP hospitals. The targeted vascular module was added in 2011 and consists of self-selected hospitals within the NSQIP that agreed to provide additional clinical data, chosen by participating vascular surgeons, to further improve the analytic power of the NSQIP and, subsequently, the quality of patient care. Additional information on the NSQIP is available at www.facs.org/quality-programs/acs-nsqip. "Any complication" included neurologic, cardiac, pulmonary, renal, sepsis/septic shock, postoperative urinary tract infection, graft failure, deep venous thrombosis, unplanned reoperation, and death. Transfusion was not included in the aggregate variable of any complication as it occurs at a high rate in this population, and we thought it was best to report it separately. Failure to rescue was defined as death after a postoperative complication, which for this calculation included patients undergoing transfusion, as previously described by Silber et al. 10 Patients were categorized as unstable rupture if they had any of the following preoperative characteristics: ventilator dependence (assumed to represent preoperative intubation in this population), preoperative transfusion, impaired sensorium, coma, preoperative acute renal deterioration (defined by the NSQIP as a creatinine value of 3 mg/dL on two laboratory draws or a physician's documentation), or American Society of Anesthesiologists (ASA) classification of 5 (moribund). For comparison, with respect to risk of mortality, this surrogate measure of unstable rupture was compared with the targeted NSQIP variable "rupture with hypotension," defined as a preoperative systolic blood pressure <90 mm Hg, drop of >40 mm Hg from baseline systolic pressure, or use of a pressor medication. Patients who died before discharge were excluded from the calculations for length of stay and readmission.
Cohorts
Statistical analysis. Continuous variables were presented as mean 6 standard deviation or as median and interquartile range as appropriate. Categorical variables were presented as counts and percentages. Univariate differences between cohorts were assessed using c 2 and Fisher exact tests for categorical variables and Student t-test and Mann-Whitney U test for continuous variables, where appropriate. We chose to use ICD-9 diagnosis to identify rupture as it could be used for all groups and it was found to perform best by k coefficient, using ruptured identification from the targeted variables as the reference, in groups in which CPT coding could also be used.
To identify independent risk factors for 30-day mortality, our primary end point, we used multivariable logistic regression models for intact and ruptured AAAs. We employed purposeful selection to initially populate our multivariable models, which uses a combination of previously identified predictors of mortality after AAA repair and variables associated with mortality on univariate screen (included if P < .10).
11 All tests were two sided, and P value < .05 was considered significant. IBM SPSS Statistics version 22.0 (IBM Corp, Armonk, NY) was used for all analysis. Permission to use deidentified data from the NSQIP, without the need for informed consent, was obtained from the Institutional Review Board at Beth Israel Deaconess Medical Center.
RESULTS
After the exclusion of 352 patients with concomitant thoracic aneurysms, our cohort consisted of 17,299 patients undergoing AAA repair in the NSQIP from years 2011 to 2013. There was no significant difference in proportion of EVAR for intact aneurysms (79% vs 77%; P ¼ .06) or for ruptured aneurysms (50% vs 45%; P ¼ .08) between targeted and nontargeted hospitals, respectively. However, the proportion of aneurysm repairs for rupture was higher at targeted hospitals (10% vs 8.7%; P ¼ .001). Of the 4986 EVARs performed at targeted hospitals, 6.7% were for ruptured aneurysms; and of the 7988 EVARs at nontargeted hospitals, 5.2% were for ruptured aneurysms (P ¼ .001 Patient characteristics. There was little difference in selection of patients between the targeted and nontargeted hospitals, for both intact and ruptured aneurysms (Table I) . For intact aneurysms, targeted hospital patients were more likely to be white (85% vs 84%; P ¼ .001) but were less likely to be current smokers (33% vs 35%; P ¼ .03) and to have a preoperative creatinine level >1.4 mg/dL (16% vs 18%; P ¼ .01). For ruptured aneurysms, targeted hospitals had a higher rate of severe chronic obstructive pulmonary disease (COPD; 20% vs 16%; P ¼ .02) but a lower rate of dependent baseline functional status (6.0% vs 9.6%; P ¼ .01). For both groups, there were a surprising number of nonemergent ruptures, with a larger proportion in targeted than in nontargeted hospitals (11% vs 6.9%; P ¼ .003).
Patient characteristics were further stratified by operation type. The intact EVAR groups were similar; however, targeted hospitals had a lower proportion with dependent functional status (2.8% vs 3.4%; P ¼ .048) and ASA classification of 4 For noncomplex open repair of intact aneurysms, there were no differences between targeted and nontargeted hospitals for mortality (4.2% vs 4.5%; P ¼ .7), any complication (28% vs 29%; P ¼ .5), failure to rescue (5.2% vs 6.3%; P ¼ .36), length of stay (7 days [6] [7] [8] [9] [10] [11] vs 7 days [6] [7] [8] [9] [10] [11] ; P ¼ .8), or readmission (7.7% vs 7.6%; P ¼ .9; Table II ). Targeted hospitals in this cohort did have a higher rate of transfusion (70% vs 60%; P < .001). Open repair for ruptured aneurysms had no difference in mortality (38% vs 34%; Bleeding removed from any complication. c In-hospital death excluded from length of stay and readmission comparisons. P ¼ .2), transfusion (89% vs 91%; P ¼ .3), or any complication (77% vs 75%; P ¼ .7) between targeted and nontargeted hospitals, but targeted hospitals did have a lower rate of readmission (3.0% vs 9.5%; P ¼ .01).
Complex EVAR and open repair. There was no difference between targeted and nontargeted hospitals within complex EVAR for intact aneurysms for both mortality (5.0% vs 3.2%; P ¼ .3) and any complication (17% vs 19%; P ¼ .6) and failure to rescue (11% vs 8.5%; P ¼ .51; Table III ). In fact, the only difference in this group was a lower readmission rate in targeted hospitals (6.5% vs 12%; P ¼ .04). Similarly, for ruptured aneurysms undergoing complex EVAR, there was no difference in mortality (29% vs 33%; P ¼ 1.0) or any complication (36% vs 57%; P ¼ .2), although this analysis had a limited sample size.
For complex open intact aneurysm repair, there were no differences in mortality (8.8% vs 6.0%; P ¼ .2), any complication (34% vs 30%; P ¼ .2), failure to rescue (11% vs 7.1%; P ¼ .11), length of stay (8 days [6-12] vs 8 days [6] [7] [8] [9] [10] [11] ; P ¼ .2), or readmission (8.2% vs 8.5%; P ¼ .9; Table III ). Targeted hospitals had a higher rate of pulmonary complications (22% vs 15%; P ¼ .01) and transfusion (76% vs 69%; P ¼ .04). For complex open repair in ruptured aneurysms, there were no significant outcome differences, including mortality (27% vs 41%; P ¼ .09) and any complication (63% vs 73%; P ¼ .2), between targeted and nontargeted hospitals.
Multivariable models for mortality
Intact aneurysms. Undergoing an AAA repair at a targeted hospital for an intact aneurysm was not independently associated with mortality (odds ratio [OR], 1.1; 95% confidence interval, 0.9-1.4; Table IV). Independent predictors of 30-day mortality for intact aneurysms identified in our model included age, preoperative hemodialysis, female sex, COPD, dependent functional status, congestive heart failure, complex repair, and open repair. Complex EVAR was found to be Table V ). In our model, independent predictors of 30-day mortality were age, dependent functional status, open repair, and unstable rupture.
Addition of the targeted variable "rupture with hypotension," in addition to our variable "unstable rupture," significantly improved the predictive ability of the model (P < .001). When we analyzed the individual components of unstable rupture, in the original model, only preoperative intubation (OR, 3. 
DISCUSSION
In this study, we found only minor differences in terms of selection and treatment, with a greater proportion of ruptured aneurysm repairs and a trend toward greater utilization of EVAR at targeted hospitals. Notably, there was no significant difference in proportion of complex aneurysm repair between the two hospital types for intact and ruptured aneurysms. All outcomes were similar between targeted and nontargeted hospitals. In adjusting for patient factors and complexity, there was no difference in 30-day mortality between targeted and nontargeted hospitals for both intact and ruptured aneurysms. There were also no differences in "any complication" rates across all subgroups evaluated. We believe these similarities speak to the consistency of care and patient selection between these hospital types and the generalizability of the targeted module to the nontargeted NSQIP. This is important as the targeted NSQIP now contains relevant anatomic and operative details that can provide further insight into patient selection and treatment approach strategies.
Prior administrative or registry studies have cited elective perioperative mortality rates for intact aneurysms of 3.2% to 5.3% for open repair and 0.6% to 1.8% for EVAR.
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These studies did not differentiate by complexity, and those that captured 30-day mortality tended to be on the higher end of these ranges and were similar to our mortality rate for intact noncomplex EVAR and open repair. Furthermore, our mortality rates are similar to the Medicare population (30-day mortality rate: EVAR, 1.6%; open repair, 4.8%), suggesting that results from the NSQIP are generalizable to the United States as a whole. 16 Our reported mortality for complex open repair was within rates previously reported for this specific population, which ranged from 0.8% to 7.9%. [17] [18] [19] [20] [21] Our mortality for complex EVAR was also similar to the mortality rate of 4.3% for fenestrated or branched EVAR seen in the WINDOW registry.
22 Our multivariable model for mortality of intact aneurysms was comparable to multiple previous studies, which found increasing age, renal disease, pulmonary disease, congestive heart failure, and open approach to be associated with increased mortality and importantly found no association between targeted hospital type and mortality. [23] [24] [25] [26] To address the concern that more complex EVARs were being performed at targeted hospitals, we identified and adjusted for this in our model. Our definition of complex EVAR, which was strongly associated with higher mortality, included use of iliac conduits, which likely overlaps with female sex. Women have already been shown to have increased mortality for intact aneurysms in prior work as well as in this study. 23, 25, [27] [28] [29] For ruptured AAA repair, there has been a clear decline over time in mortality, and our analysis showed similar rates to more recent analyses using Nationwide Inpatient Sample and Medicare. 15, 30, 31 Our multivariable model for rupture mortality was also similar to prior models and demonstrated no effect of NSQIP hospital type. 32 Previously, our group found that age, ASA classification of 5, and preoperative intubation were independently associated with mortality and that an endovascular repair was protective, using the 2005-2007 nontargeted NSQIP. 33 In our current model, the targeted variable "rupture with hypotension" was found to be a better predictor of mortality compared with our prior definition of unstable rupture; however, our prior definition was still strongly associated with increased mortality and allowed the inclusion of nontargeted hospital ruptured aneurysm repairs. Despite the overall similarity between targeted and nontargeted hospitals, there were also some notable differences. First, operative time was longer in targeted vs nontargeted hospitals, even after restricting the comparison to only straightforward repairs. Because of missing data, we were unable to evaluate degree of resident involvement as an explanation for this difference; but in years prior, when this data point was captured well in the NSQIP, resident involvement was associated with longer operative times for AAA repair. 34 We were also unable to determine if there was a difference in proportion of retroperitoneal vs transperitoneal approach for open repairs. Our recent targeted NSQIP analysis found longer operative times with the retroperitoneal approach when accounting for graft configuration (tube vs bifurcated) and higher rates of transfusion as well. 35 Importantly, however, increased operative times did not translate into increased mortality, morbidity, or length of stay. In addition to operative time, targeted hospitals also had higher rates of transfusion for noncomplex and complex intact open repairs. It was unclear whether this was from a difference in threshold for transfusion, patient factors, or higher bleeding rates. Readmission rates were similar except for noncomplex open repairs for ruptured aneurysms and complex EVARs for intact aneurysms, both being lower in targeted hospitals, despite no difference in overall complication rates or length of stay. The reason for these differences was unclear but clinically relevant as the 1-year mortality for those readmitted within 30 days of either EVAR or open elective repair has been shown to be as high as 23% compared with 4.5% for those not readmitted. 36 Unfortunately, longterm survival data are not available from the NSQIP to further evaluate this. Limitations of this study are those inherent in a clinical registry database, including missing data, limited variable definitions, and miscoding. There was a higher than expected proportion of nonemergent ruptured aneurysm repairs at both hospital types. Identification of a ruptured aneurysm is taken directly from the surgeon's operative note, and therefore we believe the larger than expected proportion of nonemergent ruptured aneurysms is likely from miscoding of the emergent status and may also include some contained ruptures that for undocumented reasons were not repaired emergently. In addition, this study contains the first 3 years of the targeted module, and because it has grown over time, it is conceivable that a nontargeted hospital in 2011 became a targeted hospital in 2012-2013. It is also possible that hospitals in the nontargeted NSQIP chose to not participate in the targeted module because they are already contributing data to other clinical registries, such as the Vascular Quality Initiative. Because the NSQIP does not provide hospital identification data, hospitals that participated in the nontargeted NSQIP one year and then in the targeted module the next or hospitals that chose to participate in either module of the NSQIP in the later years of our study but not at the beginning could not be identified. However, this is of limited importance to the focus of this study, which was to understand if conclusions drawn from the targeted NSQIP could be generalized to the whole NSQIP. This clinical registry also lacks details on hospital size, surgeon identification, and insurance coverage, all of which could have added further detail to our comparison of NSQIP hospital types. The fact that hospitals self-select into both groups in the NSQIP could lead to unaccounted for bias, although both targeted and nontargeted modules are voluntary. Despite the limitations, we view this study as an endorsement of the targeted NSQIP, and not the contrary, because we believe its increased anatomic and operative details (eg, AAA diameter, hemodynamic instability, symptomatic AAA, suprarenal aneurysm), which have been shown in prior studies to be important risk factors for outcomes, alongside the generalizability that we report here, will provide more informative methods for risk adjustment within the NSQIP to improve the quality of patient care. 23, 33, 37, 38 It is possible that this increased clinical detail in a national registry may also identify other variables that could be used in the future to better risk adjust. From a hospital perspective, the additional detail collected on its own targeted vascular cases will help each individual hospital more accurately compare its risk-adjusted outcomes with others. Furthermore, the targeted module allows hospitals to subselect particular types of cases to focus quality improvement efforts. For example, a particular hospital may choose to collect targeted data on all lower extremity bypass procedures and open AAAs but limited or no collection of targeted data for carotid endarterectomy, EVAR, and lower extremity angioplasty.
CONCLUSIONS
This analysis highlights the similarities between targeted and nontargeted hospitals within the NSQIP for AAA care, in terms of patient selection, treatments offered, and perioperative outcomes, demonstrating that results from the targeted NSQIP are generalizable to the overall NSQIP population and may be generalizable to the U.S. population as a whole, based on similar operative mortality rates to Medicare and the Nationwide Inpatient Sample. This generalizability combined with the added anatomic and operative detail in the targeted module advocates for continued use of this data set and answers the criticisms about its applicability to those undergoing vascular surgery outside of targeted hospitals. 
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